- AU$39.12m
- AU$38.09m
- AU$15.77m
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:20:09
Australia Stock Exchange release from RESONANCE HEALTH : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:33:20
Australia Stock Exchange release from RESONANCE HEALTH : Sales & Marketing Update
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:31:18
Australia Stock Exchange release from RESONANCE HEALTH : New AI Medical Device
Australia Stock Exchange release from RESONANCE HEALTH : AGM Date and Director Nomination Closing Date
Australia Stock Exchange release from RESONANCE HEALTH : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from RESONANCE HEALTH : Annual Report to shareholders
Australia Stock Exchange release from RESONANCE HEALTH : Change in substantial holding
Australia Stock Exchange release from RESONANCE HEALTH : R&D Molecular Medicine ASON Project Results of Dosing Study
Australia Stock Exchange release from RESONANCE HEALTH : Preliminary Final Report
Australia Stock Exchange release from RESONANCE HEALTH : PRE_NR Ends: 08:23:10
Australia Stock Exchange release from RESONANCE HEALTH : Change of Director's Interest Notice
Australia Stock Exchange release from RESONANCE HEALTH : Cancellation of Unlisted Options
Brief: Resonance Health Says To Raise Controlled Placement Agreement Limit To $7.75 Mln
Australia Stock Exchange release from RESONANCE HEALTH : Controlled Placement Facility - Extension and Increase
Australia Stock Exchange release from RESONANCE HEALTH : Change of Director's Interest Notice
Brief: Resonance Health Says Mitchell Wells To Transition To Role Of MD